Lamotrigina EG 100mg tablets

Lamotrigina EG is a generic medication primarily used for the treatment of epilepsy and bipolar disorder. The brand 'EG' (EuroGenerici) is one of the most prominent generic pharmaceutical brands in Italy. It was established with the goal of providing high-quality equivalent drugs at more accessible prices.

Manufacturing for the STADA Group, which owns EG, occurs across various global sites including Germany, Serbia, and Russia, depending on the specific product line and regional demand. STADA specializes in both generic pharmaceuticals and consumer health products, maintaining a diversified supply chain to serve the European market.

Today, EG operates as part of the STADA Arzneimittel AG group, a major international pharmaceutical company based in Germany. The group is currently owned by investment firms Bain Capital and Cinven, following a significant acquisition in 2017, positioning it as a leading player in the global generics market.